Tissue Engineering Market Size o Reach $6.81 Billion by 2027 Rise in Prevalence of Chronic Disease and Trauma Emergencies the Globe.

13 Aug 2021
www.biospace.com
Vaccine
Increase in need for tissue engineering in organ transplantation, rise in prevalence of chronic diseases and trauma emergencies & advancements in medical equipment technologies fuel the growth of global tissue engineering market. "Tissue Engineering Market by Type (Synthetic Scaffold Material, Biologically Derived Scaffold Material, and Others), Application (Orthopedics & Musculoskeletal, Neurology, Cardiovascular, Skin & Integumentary, Dental, and Others): Global Opportunity Analysis and Industry Forecast, 2020–2027." According to the report, the global tissue engineering industry was pegged at $2.37 billion in 2019, and is expected to hit $6.81 billion by 2027, registering a CAGR of 14.2% from 2020 to 2027. Increase in need for tissue engineering in organ transplantation, rise in prevalence of chronic diseases and trauma emergencies, and advancements in medical equipment technologies fuel the growth of the global tissue engineering market. On the other hand, high cost associated with tissue engineered products impedes the growth to some extent. However, untapped opportunities in the developing markets have proven to be highly beneficial for the growth of the industry. Request for Sample Report for More Insights@ COVID-19 scenario: The outbreak of the pandemic caused disruptions in the clinical research for tissue engineering, as funds were passed on for clinical trials for the COVID-19 vaccineCOVID-19 vaccine. Also, a number of biotech and pharmaceutical firms have carted their focus on obtaining drugs for novel corona virus. At the same time, there's been a huge fall in the number of cell and tissue donation programs since the outbreak. Consequently, such disruptions in clinical research have exerted a direct influence on tissue replacement and reconstructive surgeries as well, thereby impacting the global market for tissue engineering badly. The biologically derived scaffold material segment to retain its dominance by 2027:- Based on type, the biologically derived scaffold material segment contributed to more than half of the global tissue engineering market share in 2019 and is projected to rule the roost by the end of 2027, owing to its properties such as biocompatibility, non-toxicity, biodegradability, good cell recognition properties, and easy functionalization. Simultaneously, the synthetic scaffold material segment would portray the fastest CAGR of 16.2% throughout the forecast period. These materials are bioinert, bioactive, and bioresorbable depending on their ability to bond directly with native tissues, once implanted. This factor fuels the segment growth. The orthopedics and musculoskeletal segment to rule the roost:- Based on application, the orthopedics and musculoskeletal segment accounted for more than one-third of the global tissue engineering market revenue in 2019 and is anticipated to lead the trail by 2027. Increase in incidences of musculoskeletal disorders along with rise in awareness of tissue engineered products propel the growth of the segment. The cardiovascular segment, on the other hand, is projected to manifest the fastest CAGR of 17.4% during the forecast period. Cardiac tissue engineering mainly involves cardiac grafts, without causing side effects, such as immunogenicity. This factor drives the segment growth. North America to dominate in terms of revenue:- Based on geography, North America held the highest share in 2019, generating nearly half of the global tissue engineering market. Higher awareness regarding tissue engineering and its applications in different areas such as orthopedics, cardiology, and dermatology fuel the market growth in the province. At the same time, Asia-Pacific is expected to register the fastest CAGR of 16.3% from 2020 to 2027. Increase in demand for advanced healthcare services in emerging economies, developing R&D sector, and huge presence of key players in the region drive the market growth. Frontrunners in the industry:- B. Braun Melsungen AG Becton Dickinson and Company (C. R. BARD, INC.) Integra LifeSciences Zimmer Biomet Holdings, Inc. Organogenesis Holdings Vericel Corporation AbbVie Inc. (Allergen Plc.) Smith & Nephew Plc. (Osiris Therapeutics) Sid Martin Biotech (Axogen) TissueTech Inc. Trending Reports of Healthcare: Therapeutic Electrodes Market - Global Opportunity Analysis and Industry Forecast, 2019-2028 Tissue Ablation Market - Global Opportunity Analysis and Industry Forecast, 2019-2028 About Us: Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry. Contact: David Correa 5933 NE Win Sivers Drive #205, Portland, OR 97220 United States USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141 UK: +44-845-528-1300 Hong Kong: +852-301-84916 India (Pune): +91-20-66346060 Fax: +1(855)550-5975 help@alliedmarketresearch (dot) com
Organizations
Indications
Targets
-
Drugs
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.